newsfilter
← Latest News
GlobeNewswire·

NGM Bio to Host the First of Four Virtual R&D Events on March 30, 2022

--The four-part series titled the "Explorer Series" will showcase NGM Bio's discovery engine, myeloid reprogramming and checkpoint inhibition portfolio and program for the treatment of geographic atrophy-- SOUTH SAN FRANCISCO, Calif.,